Condition
Peritoneal (Metastatic) Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Peritoneal (Metastatic) Cancer clinical trials that are recruiting, at sites in 4 countries (most in China (2), United States (2), Portugal (1)). By phase: Phase 3 (1), Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Peritoneal (Metastatic) Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| FAPI-guided radiotherapy with cadonilimab plus chemo for colorectal cancer limited to the peritoneum | Phase 3 | Shanghai, Shanghai Municipality | Recruiting | Sep 11, 2026 |
| TLR9-based immunotherapy for peritoneal cancer with ascites | Phase 1 | Providence, Rhode Island | Recruiting | Jun 18, 2026 |
| Removal of the pancreas and visible abdominal tumors plus heated chemotherapy in the belly for pancreatic cancer that has spread to the peritoneum. | — | Shanghai, shangaiShanghai Municipality and 2 other locations | Recruiting | Mar 25, 2026 |
| Biopsy and Resection Growth Patterns in Colorectal Peritoneal Cancer | — | Brussels, Brussels Capital and 1 other locations | Recruiting | Mar 16, 2026 |
| Heated versus aerosolized chemotherapy delivered into the abdomen for cancer that has spread to the peritoneum | Phase 2 | Pittsburgh, Pennsylvania | Recruiting | Dec 15, 2025 |
All recruiting trials (5)
-
FAPI-guided radiotherapy with cadonilimab plus chemo for colorectal cancer limited to the peritoneum
Aims to see if adding targeted radiotherapy and cadonilimab immunotherapy to standard second-line chemotherapy helps adults with colorectal cancer that’s spread only to the peritoneum.
-
TLR9-based immunotherapy for peritoneal cancer with ascites
This trial tests ACM-CpG injections into the abdomen to see if it’s safe and can help people with peritoneal metastases or malignant ascites from colorectal or appendiceal cancer.
-
Removal of the pancreas and visible abdominal tumors plus heated chemotherapy in the belly for pancreatic cancer that has spread to the peritoneum.
This trial will test whether removing the pancreas and visible abdominal tumors followed by heated intraperitoneal chemotherapy is safe and feasible for adults with pancreatic ductal adenocarcinoma who have limited peritoneal spread and have responded to at least six months of systemic chemotherapy.
-
Biopsy and Resection Growth Patterns in Colorectal Peritoneal Cancer
This study tests whether peritoneal growth patterns seen on small biopsies during staging laparoscopy match the patterns found in later surgical specimens for adults with colorectal peritoneal metastases.
-
Heated versus aerosolized chemotherapy delivered into the abdomen for cancer that has spread to the peritoneum
This study will test whether heated (HIPEC) or aerosolized (PIPAC) mitomycin-based chemotherapy given into the abdomen works better and is safer for adults whose cancer has spread to the peritoneum.
Related topics
Quick answers
How many Peritoneal (Metastatic) Cancer clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (2 trials), United States (2 trials), Portugal (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.